04:43 PM EST, 11/12/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 10, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,600,830. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000110657825000029/xslF345X05/primarydocument.xml